Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
06/30/2022 | 249.04% | HC Wainwright & Co. | → $2 | Initiates Coverage On | → Buy |
NRX Pharmaceuticals Questions & Answers
The latest price target for NRX Pharmaceuticals (NASDAQ: NRXP) was reported by HC Wainwright & Co. on June 30, 2022. The analyst firm set a price target for $2.00 expecting NRXP to rise to within 12 months (a possible 249.04% upside). 1 analyst firms have reported ratings in the last year.
The latest analyst rating for NRX Pharmaceuticals (NASDAQ: NRXP) was provided by HC Wainwright & Co., and NRX Pharmaceuticals initiated their buy rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NRX Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NRX Pharmaceuticals was filed on June 30, 2022 so you should expect the next rating to be made available sometime around June 30, 2023.
While ratings are subjective and will change, the latest NRX Pharmaceuticals (NRXP) rating was a initiated with a price target of $0.00 to $2.00. The current price NRX Pharmaceuticals (NRXP) is trading at is $0.57, which is within the analyst's predicted range.